Eton Pharmaceuticals マネジメント
マネジメント 基準チェック /44
Eton Pharmaceuticalsの CEO はSean Brynjelsenで、 Jun2017年に任命され、 の在任期間は 7.42年です。 の年間総報酬は$ 1.75Mで、 33.9%給与と66.1%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の4.16%を直接所有しており、その価値は$ 10.77M 。経営陣と取締役会の平均在任期間はそれぞれ2.6年と7.2年です。
主要情報
Sean Brynjelsen
最高経営責任者
US$1.7m
報酬総額
| CEO給与比率 | 33.9% |
| CEO在任期間 | 7.4yrs |
| CEOの所有権 | 4.2% |
| 経営陣の平均在職期間 | 2.6yrs |
| 取締役会の平均在任期間 | 7.2yrs |
経営陣の近況
Recent updates
Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 29%
Nov 14
Is Eton Pharmaceuticals (NASDAQ:ETON) A Risky Investment?
Oct 07After Leaping 26% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar
Sep 10Subdued Growth No Barrier To Eton Pharmaceuticals, Inc. (NASDAQ:ETON) With Shares Advancing 40%
Jan 09The Consensus EPS Estimates For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Just Fell A Lot
Dec 13Eton Pharmaceuticals' (NASDAQ:ETON) Earnings May Just Be The Starting Point
Nov 16Here's Why Eton Pharmaceuticals (NASDAQ:ETON) Can Manage Its Debt Despite Losing Money
Sep 30Not Many Are Piling Into Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Stock Yet As It Plummets 26%
Jul 25Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?
Jun 29Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?
Dec 22Eton Pharmaceuticals acquires FDA-approved rare disease product betaine anhydrous
Sep 13Eton Pharmaceuticals: An Evolving 'Sum Of The Parts' Story
Aug 14Eton Pharma jumps 20% on FDA approval of seizure therapy
Jul 18Broker Revenue Forecasts For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Are Surging Higher
Apr 15Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely
Oct 14Another Look At Eton Pharmaceuticals
Sep 03What Does The Future Hold For Eton Pharmaceuticals, Inc. (NASDAQ:ETON)? These Analysts Have Been Cutting Their Estimates
Aug 18Eton Pharma wins FDA approval for Rezipres
Jun 15FDA declines to approve Eton Pharmaceuticals' methanol poisoning treatment
May 28Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Is About To Turn The Corner
May 15Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?
Apr 05Could The Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Ownership Structure Tell Us Something Useful?
Mar 01Eton Pharma buys Canadian rights for Alkindi Sprinkle
Jan 14Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Shift From Loss To Profit
Jan 07
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$5m |
| Jun 30 2024 | n/a | n/a | -US$7m |
| Mar 31 2024 | n/a | n/a | US$913k |
| Dec 31 2023 | US$2m | US$592k | -US$936k |
| Sep 30 2023 | n/a | n/a | US$2m |
| Jun 30 2023 | n/a | n/a | -US$234k |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | US$2m | US$570k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$9m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$12m |
| Dec 31 2021 | US$2m | US$542k | -US$2m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$2m | US$476k | -US$28m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$21m |
| Mar 31 2020 | n/a | n/a | -US$20m |
| Dec 31 2019 | US$2m | US$410k | -US$18m |
| Sep 30 2019 | n/a | n/a | -US$42m |
| Jun 30 2019 | n/a | n/a | -US$40m |
| Mar 31 2019 | n/a | n/a | -US$41m |
| Dec 31 2018 | US$493k | US$332k | -US$37m |
| Sep 30 2018 | n/a | n/a | -US$18m |
| Dec 31 2017 | US$654k | US$172k | -US$13m |
報酬と市場: Seanの 総報酬 ($USD 1.75M ) は、 US市場 ($USD 1.46M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Seanの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Sean Brynjelsen (52 yo)
7.4yrs
在職期間
US$1,747,045
報酬
Mr. Sean E. Brynjelsen has been the Chief Executive Officer at Eton Pharmaceuticals, Inc. since June 23, 2017 and serves as President and Director since June 2017. Mr. Brynjelsen served as Executive Vice P...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 7.4yrs | US$1.75m | 4.16% $ 10.8m | |
| CFO, Treasurer & Secretary | 2.6yrs | US$785.14k | 0.049% $ 126.3k | |
| Chief Business Officer | 1.7yrs | US$719.08k | 0.081% $ 208.4k | |
| Senior Vice President of Quality & Operations | less than a year | データなし | データなし | |
| Vice President of Sales Operations | no data | データなし | データなし | |
| Executive VP of Commercial Operations | 2.8yrs | データなし | データなし |
2.6yrs
平均在職期間
52yo
平均年齢
経験豊富な経営陣: ETONの経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 7.4yrs | US$1.75m | 4.16% $ 10.8m | |
| Independent Director | 7.2yrs | US$129.50k | 0.23% $ 598.7k | |
| Independent Director | 7.4yrs | US$126.90k | 0.26% $ 685.6k | |
| Independent Chairman | 7.2yrs | US$155.50k | 0.23% $ 598.7k | |
| Independent Director | 3.7yrs | US$119.10k | データなし |
7.2yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: ETONの 取締役会 は 経験豊富 であると考えられます ( 7.2年の平均在任期間)。